PANC.US Panacos Pharmaceuticals Inc

Healthcare Biotechnology USA Stocks
- USD
Market cap
-
P/E
-
P/B
-
ROE
-667.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2008.

Is PANC.US undervalued?

Graham number

The Graham number of Panacos Pharmaceuticals Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Panacos Pharmaceuticals Inc fundamental analysis

No fundamental analysis for Panacos Pharmaceuticals Inc yet.

Panacos Pharmaceuticals Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Panacos Pharmaceuticals Inc

Panacos Pharmaceuticals, Inc., a development stage biotechnology company, engages in the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The company's discovery technologies focus on novel targets in the virus life cycle, including virus maturation and virus fusion. Its product pipeline includes second- and third-generation programs in HIV maturation inhibition. The company was founde…

Full company profile